⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GERN News
Geron Corp
Form 8-K
sec.gov
GERN
Geron Corporation Provides Update on Phase 3 IMpactMF Clinical Trial of Imetelstat in Relapsed/Refractory Myelofibrosis
globenewswire.com
GERN
Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026
globenewswire.com
GERN
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
GERN
Geron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and Asia
globenewswire.com
GERN
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com
GERN
Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN
prnewswire.com
GERN
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
GERN
RYTELO (Imetelstat) Clinical, Regulatory and Commercial Intelligence Report 2026-2034
globenewswire.com
GERN
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com
GERN